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This thesis presents a study on the enhancement of CHO cell growth by Yeast extract, Yeastolate, 
and Primatone fractions obtained by dead-end ultrafiltration. The total solid, peptide contents, 
antioxidant capacity and hydrophobicity of the fractions were evaluated. 
 
The objective of this project was to evaluate the potential of sequential ultrafiltration as an 
effective, simple and economical method for the identification of CHO cell growth enhancement 
components in yeast extract and yeastolate (primatone). 
 
The fractionation by sequential ultrafiltration (50 kDa membrane, 3 kDa membrane and 1 kDa 
membrane) of  yeast extract (YE), yeastolate (YET), and primatone (PRI) showed different 
fouling and fractionation behaviour. Significant fouling was observed with the 50 kDa and 3 kDa 
membrane while negligible fouling was observed with the 1 kDa membrane. Similar and more 
significant fouling was observed with the 50 kDa membrane and for YE and PRI in comparison 
to YET. In contrast, more fouling was observed during the ultrafiltration with the 3kDa MWCO 
and for YE and YET in comparison to PRI. Finally a relatively constant permeate flux was 
obtained with the 1 kDa membrane, with PRI the highest and YET the lowest permeate flux. 
Different total peptide contents were present in the three feeds, 410, 327 and 300 mmol Phe-Gly 
equivalent/ g total solids for YE, PRI and YET respectively. In spite of different feed equivalent 
Phe-Gly, all three feeds contained a similar amount of equivalent Phe-Gly with molecular weight 
larger than 50 kDa, 15-19% of the initial feed stream. This was similar amount to the total solids 
content. The total peptide content of the retentate obtained for the 3kDa filtration indicated that 
YE and YET contained ~ 20% of equivalent Phe-Gly larger than 3 kDa but smaller than 50kDa. 
In contrast, PRI contained only 6% of equivalent Phe-Gly with such molecular weight. The 




for YE and 38% for YET (p< 0.05).  All three feeds have similar total peptide content smaller 
than 1 kDa. For any given feed, the equivalent Phe-Gly was larger than 1 kDa but smaller than 3 
kDa predominated. The total peptide content profile according to size coincides with the total 
solids distribution for all three feed types. This is the first study that reports on the total peptide 
content for YE, YET, and PRI subjected to ultrafiltration fractionation.  
 
All three feeds and their fractions when freeze-dried had similar antioxidant capacity estimated 
by the FCR (Folin-Ciocalteu reagent) assay, ~ 40-50 mg Trolox/g sample. 
 
The bioactivity of feed and fractions was measured as cell density for CHO (beta-IFN producers) 
in basal medium supplemented with a combination of the crude non-fractionated feed material 
and a specific fraction and grown in T25 flasks. PRI showed a similar growth enhancement 
effect for all fractions when compared to a culture supplemented with the crude non-fractionated. 
YE showed no growth enhancement for any of the fractions when compared to a culture 
supplemented with the crude non-fractionated YE. This observation need to be confirmed as a 
culture supplemented with the crude non-fractionated YE showed a very high growth stimulating 
effect which was much higher than PRI and YET at the same concentration. Finally, YET 3kDa 
retentate fraction displayed a 50 % growth enhancement effect. In conclusion, the fractions 
obtained from the two non-animal protein hydrolysates considered in this study, YE and YET 
showed limited CHO cell growth enhancement effect when compared to the non-fractionated 
material. Only the YET 3kDa retentate fraction displayed a good CHO cell growth enhancement 
effect. YET 3kDa represent an attractive serum substitute for its use in culturing CHO cells. PRI, 
an animal derived protein hydrolysate showed the best growth enhancement effect for all 
fractions produced in this study. These results suggest that YET has high potential as a media 
additive for the development of serum-free media which can promote cell growth and, in the 
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Chapter 1 Introduction 
1.1 Research aim and outline 
 
Animal cell cultures have been important on a laboratory-use scale for most of the last few 
decades. The initial need for human viral vaccines in the 1950s (particularly for poliomyelitis) 
accelerated the design of large-scale bioprocesses for mammalian cells (Maurice 2002). 
In the last few years, there has been a rapid increase in the number and demand for glycoprotein 
produced from animal cell culture processes.   Animal cells have complex nutrient requirements 
which are specific to a given cell line and glycoprotein. For the production of therapeutic 
proteins, a serum-free media is desirable because the use of serum has many drawbacks: 
undefined composition, high protein levels, risk of contamination by viruses, mycoplasma, 
Bovine Spongiform Encephalopathy, variable quality, and high cost. In contrast, serum-free 
media have many advantages: more defined components, a controlled cell culture environment, 
and low cost. Although much effort has been devoted in developing serum-free media for 
mammalian cells, such as low-cost hydrolysates contain undefined mixtures such as amino-acids, 
peptides, vitamins, and trace elements, sometimes using these low-cost hydrolysates result in 
decreased cell growth, because impurities interrupt the growth process (Zhang et al. 1994). 
Since serum is a supplement of unknown composition, which could be contaminated with 
unwanted factors, there are scientific and safety reasons for omitting fetal bovine serum from 
culture media. Several media have been developed in which minimal or no animal derived 
components are present. But as yet, no standard serum free media has been developed to fulfill 
the nutritional requirements of each cell type.  
A method is needed to separate and define the components providing growth enhancement from 
low-cost serum-free media ingredients. In this project (Figure 1.1), ultrafiltration was considered 
as a simple and low cost alternative for the fractionation of growth enhancing ingredients 
contained in  non-animal derived hydrolysates such as yeast extract (YE) and yeastolate (YET), 




obtained by the ultrafiltration process were characterized for their total peptide content, 
antioxidant capacity and relative hydrophobicity. 
The biological activity of CHO cell density produced using YE, YET, and PRI was also 
examined by measurement of the cell density for specific CHO cell line. 
 
                  
         Figure 1.1 Schematic of approach 
1.2 Structure of the thesis 
 
Chapter 2 presents the objectives of this study. The background information on non-animal 
protein hydrolysates, dead-end ultrafiltration, antioxidant activity, RP- HPLC, CHO cell culture, 
and aggregation is provided in Chapter 3. The equipment and analytical techniques employed for 
this work are described in the materials and methods, Chapter 4. The experimental results and 
discussion are presented in Chapter 5 and 6. Chapter 7 contains the conclusions of this work and 




Chapter 2 Objectives 
 
The overall objective of this work was to fractionate by sequential membrane ultrafiltration two 
non-animal protein hydrolysates, yeast extract and yeastolate, and one animal protein 
hydrolysate, primatone and produce additives for CHO cell medium supplementation. Specific 
objectives were as follows: 
 
 Characterize ultrafiltration membrane performance for hydrolysate fractionation 
(membrane fouling, total solids and total peptide retention). 
 Evaluate antioxidant capacity and hydrophobicity of the fractionated hydrolysates 













Chapter 3 Literature Review 
3.1 CHO Cell Culture 
 
Chinese hamster ovary (CHO) cells are the most widely used for transfection, expression, and 
large-scale recombinant protein production. They have been adapted for growth in suspension 
culture and are well-suited for scale-up in stirred tank bioreactors. The advantages of CHO cells 
are to provide stable and accurate glycosylation, offer a post-translationally modified product 
and more accurate in vitro rendition of natural protein (Sheeley 1997). CHO cells are robust in 
culture and are able to produce a variety of recombinant glycoproteins at high levels on a large 
scale. There is tremendous work to produce pharmaceutical product trough the CHO cells: hTPO 
(Kaszubska et al 2000, Sung et al. 2004), IFN-γ (Burteau 2003).   
There has been a rapid increase in the number and demand for approved biopharmaceuticals 
produced from animal cell culture processes over the last few years. Figure 3.1 shows the 
increase in the number of biopharmaceuticals approved for production by mammalian cell 
bioprocesses over the last 20 years with the actual and expected demand in kilograms. The sharp 
increase in the years 2000 is largely due to the number of approved therapeutic antibodies that 







Figure 3.1 The demand for mammalian cell culture products (Molowa and Mazanet, 2003). 
 
The commercial significance of these products as therapeutics is driving a vigorous interest for 
progress in process development using mammalian cell cultures. The high clinical dosage 
requirements for antibodies leads to large volume demands in biomanufacture (estimated to be 
>2000kg for all biotherapeutic proteins). Because of the high demand for individual antibodies, 
the cost efficiency in manufacture becomes extremely important (Butler2007). 
However, different CHO cell clones often possess diverse nutritional requirements that are 
unique to each clone. As a result, medium optimization for CHO cells can be very challenging, 
often requiring the development of a custom medium for each particular clone.  
3.1.1 Types of cell culture media 
 
The basic nutrient requirement for mammalian cells was studied in 1955 by Eagle.  In that study, 




Classical cell culture medium contains glucose, amino acids, vitamins, trace metals, buffer, 
inorganic salts, and proteins to meet the nutrient demands and process-control demands of the 
mammalian cell culture. The composition of these components can affect cell growth, protein 
production, protein quality, and downstream protein purification. Depending on the application, 
supplements are often added, the most common one being animal-derived serum. Variation of 
the serum-containing medium has been developed.  
Fetal bovine serum, in particular, is commonly used as a supplement to classical media (Gruber 
and Jayme, 1994; Jayme and Gruber 1994). Serum provides sterols, fatty acids, growth factors, 
protein stability, and protein transporters, trace metals, vitamins, and shear protection to 
mammalian cell cultures. Removing serum without addressing these functions could result in 
poor cell growth and performance. However, not all of these functions are critical for every cell 
line. Successful serum replacements reported in the literature should be explored in statistically 
design experiments to determine the main or interacting factors that are required for the process 
medium.  
Removing the animal additives, serum, reduces the risk of viral contamination, increased process 
robustness (by reducing exposure to lot-to-lot variability of animal-source ingredients), reduces 
medium costs, and simplifies down-stream purification (Barnes 1987, McKeehan 1990). 
Especially, bovine spongiform encephalopathy (BSE) was a major factor in the move away from 
animal origin raw materials in the manufacture of human biotherapeutics.  Lastly, serum 
introduces an unknown variable into the culture system. 
Serum-free media are therefore a subset of all media, in which cells are capable of expanding 
and expressing a product in the absence of serum supplementation (Figure 3.2). To eliminate the 
use of serum, it is necessary to understand the many functions of serum, which include 
binding/carrier functions for lipids, hormones, growth factors, attachment factors, cytokines, and 
trace metals, as well as bulk protein functions like protease inhibition, shear protection and 
buffering (Jayme and Blackman, 1985). Early serum-free media often contained one or more 
serum function like albumin or fetuin, in addition to insulin, transferring, a source of lipids (often 




vitamins, and carbohydrates compared to classical media. Some literature reports on the 
development of serum-free medium by supplementing the medium with sterols and fatty acids. 
Cholesterol with methyl b-cyclodextrin (Gorfien et al. 2000), cis-unsaturated fatty acids (Butler 
and Huzel 1995, Liu et al. 2001), and ethanolamine and yeast extract (Liu et al. 2001) have been 
shown to result in increased growth and productivity in serum-free medium. Another method to 
increase the fatty acids for cells in serum-free medium is to supply insulin, which stimulates the 
biosynthesis of fatty acids (Komolov and Fedotor 1978). Medium supplement for the 
enhancement of growth are low molecular weight substance (Schlaeger 1996). 
There is one report that the serum- free media (SFM) has more positive effect on mammalian cell 
culture than serum based media (Schlaeger 1996). Reduction or substitution of serum in culture 
media of mammalian cells (growth in suspension culture) has many well known advantages 
(Iscove 1984, Glassy 1988).  
There are many studies suggesting that serum could be replaced by using low-cost commercial 
protein hydrolysates from animal tissues (peptones, tryptose), milk product (lactalabumin, 
casein), micro-organisms (yeast extract, Bacto-peptone) (Mitsuhashi and Maramorosch 1964, Jan 
1994, Schlaeger 1996). 
Cells often required a period of adaptation to SFM and it soon became apparent that a ‘universal 
SFM’ did not exist. As SFM came to be used more frequently for biological production 
applications, it also became apparent that the undefined nature of some of the medium 
constituents represented a potential cause of culture performance variability. Of greater concern 
was the potential for transmission of adventitious agents from the animal-derived medium 
components to patients receiving a biological therapeutic or prophylactic that had been produced 
in cultured cells. These factors have led to development of protein free media (PFM) and 
chemical defined media (CDM). PFM is a subset of SFM (Figure 3.2). It should be noted that 
there are many commercially available sources of cell culture media and not all suppliers use the 





PFM: Protein-Free Media contain no proteins, but may contain plant or yeast 
hydrolysates. Many are animal-origin-free. (GIBCO 
®
) 
CDM: a formulation in which the chemical structure of each component is known. 
This is another potential source of confusion among different manufactures of cell 
culture media. Some manufacturers consider media that contain proteins like insulin 
or transferring to be chemically defined while others’ definitions require that a CDM 
must also be protein-free (Gorfien 2007). Chemically fully defined means a medium 
that does not contain any complex additives such as lipid mixtures, hydrolysates, 
peptides or proteins or other, even recombinant, growth factors (Van der Valk 2004). 
 
From the US 5512477 patent 1996, a serum-free eukaryotic cell culture medium supplement 
comprises carbon sources, vitamins, inorganic salts, amino acids and a protein digest. The 
medium supplement of the present invention enables the maintenance of mammalian cell 
cultures at cell densities equal to or greater than that obtained with batch culture methods while 
increasing longevity and productivity.  
From the Robert 1975 in nature, the factors that control growth are probably polypeptide, 
hormones, or hormone-like materials, as well as a variety of low molecular weight nutrients. An 
understanding of the control of growth of mammalian cells will probably be found in the 






Figure 3.2 Different types of culture media.  
 
3.2 Non-animal Protein Hydrolysates as additives 
 
Non-animal hydrolysates have been reported to be attractive as additives for the development of 
serum-free media.  
3.2.1 Yeast  
 
Yeasts are a growth form of eukaryotic microorganisms classified in the kingdom Fungi. 
Saccharomyces cerevisiae is the one of the yeast species among 1,500 species. Yeast size can be 
varying greatly depending on the species, typically measuring 3 to 4 micrometers in diameter, 
although some yeast can reach over 40 micrometers.  
Yeasts do not form a specific taxonomic or phylogenetic grouping. At present it is estimated that 
only 1% of all yeast species have been described. The term "yeast" is often taken as a synonym 
for Saccharomyces cerevisiae, however the phylogenetic diversity of yeasts is shown by their 
placement in both divisions Ascomycota and Basidiomycota. The budding yeasts ("true yeasts") 




The useful physiological properties of yeast have led to their use in the field of biotechnology. 
Fermentation of sugars by yeast is the oldest and largest application of this technology. Many 
types of yeasts are used for making many foods: Baker's yeast in bread production, brewer's 
yeast in beer fermentation, yeast in wine fermentation and for xylitol production. Yeasts are also 
one of the most widely used model organisms for genetics and cell biology. Saccharomyces 
cerevisiae, is used in baking as a leavening agent, where it converts the fermentable sugars 
present in the dough into carbon dioxide. 
Growth conditions are following; yeasts are able to grow in food with low pH (5.0 or lower) and 
in the presence of sugars, organic acids and other easily metabolized carbon source. Yeasts will 
grow over a temperature range of 10 °C to 37 °C, with an optimal temperature range of 30 °C to 
37 °C.  
3.2.2 Yeast extract 
 
Yeast extract are concentrate of the water-soluble portion of Saccharomyces cerevisiae cells that 
have been autolyzed. The autolysis is carefully controlled to preserve the naturally occurring B-
complex vitamins. Yeast extract is considered a non-animal product and is used extensively for 
many non-animal formulations for bacterial, fungal, mammalian and insect cell culture.  
Yeast extract have calcium, magnesium, potassium, sodium, chloride, sulfate, phosphate (BD 
element analysis catalogue 2007). 
Yeast extract is the common name for various forms of processed yeast products that are used as 
food additives or flavours. They are often used in the same way that monosodium glutamate 
(MSG) is used, and like MSG, often contain free glutamic acids. The general method for making 
yeast extract for food products such as Vegemite and Marmite on a commercial scale is to add 
salt to a suspension of yeast making the solution hypertonic, which leads to the cells shriveling 
up. This triggers autolysis, where the yeast's digestive enzymes break their own proteins down 




complete their breakdown, after which the husks (yeast with thick cell walls which would give 
poor texture) are separated. 
Braz and Allen 1939, showed that the growth of several strains of streptococci and lactobacilli in 
milk culture was stimulated by the addition of yeast extract. These authors suggested that amino 
acids, which the yeast extract supplied, stimulated the cells to synthesize protein. 
Smith 1973, yeast extract was fractionated on Sephadex G-25 into 7 fractions. The fraction most 
stimulatory to the growth of streptococcus lactis C10 contained over 70% of the amino N present 
in yeast extract and consisted of a wide variety of free amino acids and a small amount of peptide 
material. 
Sung et al 2004, yeast hydrolysate was one of their serum free medium supplements for human 
thrombopoitin production of recombinant CHO cells. Among various hydrolysates tested, the 
positive effect of yeast hydrolysate on human thrombopoitin production was most significant.  
 Some works were carried out using different bioactive substance of YE. The beneficial effect of 
YE on the growth of lactic acid bacteria (LAB) is well established (Smith et al. 1975; 
Aeschlimann and von Stockar 1990). YE are an excellent source of the B-complex vitamins and 
are often used to supply these factors in bacteriological culture media (Difco product broacher 
1984). They are also a reliable source of peptides and amino acids. Amino acids and peptides 
stimulate the growth of LAB and they have been shown to be partially responsible for YE 
stimulation of the growth of lactic cultures. Peptides can be superior to free amino acids as 
nitrogen sources for LAB because they can provide the cell with amino acids in a form that can 
be utilized more efficiently. Some commercial applications, microbiological media for example, 
require that YE produce clear solutions.  
Gaudreau et al (1999) have compared the effect of ultrafitration of yeast extracts on their ability 
to promote lactic acid bacteria growth. Five yeast extracts (YE) with three from bakers’ yeasts 
(A, B, E) while two were from brewers’ yeasts (C, D) were fractionated by ultrafiltration (UF) 
with 1, 3, and 10kDa molecular weight cutoff membranes, concentrated by freeze-drying, and 




properties on nine cultures of LAB. When Gaudreau was under the experiment, there was a need 
for growth-promoting properties evaluation of YE and YEF. An automated turbidimetric 
instrument was used to assess the effect of YE or YEF added to the base medium on the increase 
in turbidity of the cultures. The method described by Champagne et al. (1999) was used. Sterile 
media having various YE and YEF were prepared in test tubes, inoculated at 1% (v/v) from a 
fresh culture, and 350-μL samples were added aseptically to each microwell. Microplates were 
incubated for 24 h at 37°C for the lactobacilli as well as the pediococci, and at 22°C for the 
lactococci. The absorbency at 600 nm of each microwell was automatically recorded. There was 
an increase in α-amino nitrogen content of the YEF powders as the pore size of the UF 
membranes used to filter the YE solutions decreased. The source of YE had a much greater 
effect than UF on the growth of LAB. This was also the case for the YEF contents in total and α-
amino nitrogen. Growth curves of the LAB showed that maximum growth rate (μmax) data were 
on average 30% higher with bakers’ YE than with brewers’ YE, while maximum optical density 
(ODmax) values were on average 16% higher with bakers’ YE. This could be related to the higher 
nitrogen content of the bakers’ YE used in this study. Modification by UF of the YE had no 
significant influence on the growth of 4 of the 9 LAB strains. The three strains of Lactobacillus 
casei were negatively influenced by UF, as they did not grow as well in the media containing the 
YEF obtained after filtering with 1 and 3 kDa membranes. On a total solids basis, the 2.5 times 
retentates from the 10 kDa membrane gave, on average, 4% lower μmax and 5% lower ODmax 
values as compared to cultures where the corresponding YEF was used as medium supplement. 




Yeastolate is highly filterable, aqueous extract of Baker’s or Brewer’s yeast through autolysis. 





Yeastolate contains undefined mixture of amino acids, peptides, polysaccharides, vitamins, and 
minerals (Sommer et al 1996). Many efforts have been dedicated to screen yeastolate and to 
identify active components which support the cell growth and fermentation.  
In Shen et al 2007, Yeastolate is effective in promoting growth of insect cell and enhancing 
production of recombinant protein, thus it is a key component in formulating serum-free medium 
for insect cell culture. However, yeastolate is a complex mixture and identification of the 
constituents responsible for cell growth promotion has not yet been achieved. This study used 
sequential ethanol precipitation to fractionate yeastolate ultrafiltrate (YUF) into six fractions 
(F1–F6). Fractions were characterized and evaluated for their growth promoting activities. 
Ultrafiltrated by using a Pall lab tangential flow system equipped with Omega membrane (10 kD 
MWCO). 
 
3.2.4  Primatone 
 
Primatone RL is another protein hydrolysate of a complex nature which supports mammalian 
cell growth. Primatone RL, and enzymatic digest of US meat, has been used extensively to 
reduce or replace fetal calf serum in vertebrate media for cultures of human and rodent cells, 
with no reduction in performance. 
Primatone RL was originally described as a replacement for serum (Velez et al., 1986). The 
tryptic meat digest primatone RL is a low-cost medium supplement of a complex nature which 
serves as a source of amino acids, oligopeptides, iron salt, some lipids and other trace low 
molecular weight substance. Its addition to mammalian and insect cell culture media 
significantly improves the cell growth properties of many cell lines. 
Schlaeger 1992 demonstrated that addition of the protein hydrolysate to a culture medium 
containing fatal calf serum, promotes growth depending on the medium used. The positive effect 




serum-free cultures. Its addition to mammalian and insect cell culture media improves cell 
growth properties significantly. 
At the early time, 1977, the primatone RL was expected as serum substitute on baby hamster 
kidney (BHK) cell culture. However the result of BHK cell numbers was almost half compared 
to serum based medium.    
Gu 1997, indicates that serum-free media have been widely used in mammalian cell culture for 
therapeutic protein production, the effects of serum-substitutes on product quality have not been 
extensively examined. This study observed an adverse effect of Primatone RL, an animal tissue 
hydrolysate commonly used as a serum-substitute to promote cell growth, on sialylation of 
interferon-g (IFN-g) derived from Chinese hamster ovary (CHO) cell culture in both batch and 
fed-batch modes. However, the effect of serum-substitutes on product quality also demands 
consideration to ensure that product efficacy is not compromised. The results of these 
experiments have indicated that the use of Primatone RL can adversely affect sialylation of 
CHO-derived IFN-g in both batch and fed-batch modes. The observation of diminished 
sialylation at the optimal concentration of peptone for cell growth and product yield in the batch 
mode illustrates the potential trade off between product quantity and quality which must be 
evaluated in the use of serum-substitutes.  
Schlaeger 1999 work, the growth promoting effects of Primatone RL are described in more detail 
using different mouse hybridomas, a mouse myeloma cell line, and human promyelocytic 
leukemia HL-60 cells. The positive effects on cell growth induced by primatone were observed 
in the presence of serum but were even more pronounced in serum-free culture. In addition the 
adaptation time from high serum to low (1%) or serum-free growth in the presence of Primatone 
is also significantly reduced. Primatone RL, when added to HL and DHI medium (chemically 
defined culture medium from Lonza), improves cell growth under low serum or serum-free 
conditions by increasing the maximum cell numbers and in particular the viability of the culture. 
The observed decrease in cell death (apoptosis) induction leads to a significant improvement in 





3.2.5 Other plant protein hydrolysates 
 
Many research proposed that soy protein hydrolysate, wheat gluten hydrolysate could be other 
option. Franek et al 2000 considered two plant enzymic hydrolysate, soy protein and wheat 
gluten that were separated using ultrafiltration to culturing mouse hybridoma ME-50. Individual 
peptide fractions of the hydrolysate were analyzed; the amino acid composition of the total 
hydrolysate was determined.  Fractions were varied significantly in their growth promoting and 
production-enhancing activities. Other researchers considered the rapeseed hydrolysates as an 
alternative to serum in CHO cell culture media (Frages-Haddani et al, 2006).  They collected the 
fraction using the 3 kDa and 1kDa MWCO ultrafiltration and nano-filtration.  The smallest size 
(< 500Da) peptide fraction had most significant enhancement of CHO cell growth.  
Chun et al 2007, investigated the effect of various hydrolysates was investigated on CHO cell 
media; one is being soy protein hydrolysate. The soy protein hydrolysate was filtered by 10, 5 
and 3 kDa ultrafiltration. From this work we can see the effect of hydrolysate concentration of 
soy protein and effect of ultrafilterated hydrolysate on cell growth.   
3.3 Ultrafiltration  
3.3.1 General concept of ultrafiltration 
 
Ultrafiltration uses polymeric membranes to retain macromolecules while allowing low 
molecular weight solutes and water to pass through the membrane under pressure. Ultrafiltration 
is widely used to concentrate (or dewater) a solution and remove low molecular weight 






Figure 3.3 Pressure-driven membrane ultrafiltration separation characteristics. 
 
3.3.2 Membrane properties 
 
The pore size of ultrafiltration membrane is typically characterized by molecular weight cut-off 
(MWCO), which indicates the molecular weight of a component with 90% membrane retention. 
The key component of a membrane separation system is the membrane itself. A membrane is 
defined as a thin barrier or film through which solutions and solutes are selectively transported. 
Membrane must have: high hydraulic permeability, appropriate sieving property (selectivity), 
good mechanical durability, and good chemical and thermal stability, compatibility with 
substance being processed, excellent manufacturing reproducibility, and ease of manufacture 





3.3.3 Membrane material and chemistry 
 
Ultrafiltration membranes are prepared from organic polymers or inorganic material (such as 
glass, metals and ceramics) (Kulkarni et al1992). Polymeric materials such as Polysulfone(PS), 
In Figure 3.4, polyethersulfone(PES), cellulose acetate(CA), regenerated cellulose, 









Figure 3.5 Structure of cellulose, cellulose triacetate (CT) and regenerated cellulose (RC) 
(adapted from Cheryan 1986) 
 
Figure. 3.5 show the chemical structures of some of the organic polymeric material used for 
membrane preparation. Polysulfone, polyethersulfone and cellulose based membranes are more 
widely used than other types of polymeric membranes. Organic polymer based membranes are 
more popular than inorganic membranes, due to following reasons;  inexpensive, easy to 
prepared, light and flexible to be moulded into various shapes and sizes, certain membrane 
types(hollow fibres) can only be prepared with organic polymers, and a wide range of membrane 
chemistry is available. 
 
3.3.4 Ultrafiltration operation mode 
There are two important operation modes in ultrafiltration. One is dead-end or conventional 
filtration and the other is cross-flow or tangential flow filtration (Figure 3.3). Some ultrafiltration 
equipment such as the pleated cartridges is operated in the dead-end mode, in which the feed is 




stream (called the permeate or filtrate) leaving the filter. The other UF modules are operated in 
the cross-flow mode, in which the feed is pumped tangentially to the membrane surface. On this 
mode of operation, there is one stream entering the module and two streams leaving the module 
which are called retentate and permeate. If the feed contains relatively high solids and the solid 
need to be recovered easily, cross-flow is advantageous in that it limits the build up of the solids 
on the membrane surface (shown in figure 3.6 as the ‘cake’).   
In dead-end filtration the flow causes the build-up of the filter cake, which may prevent efficient 
operation. This is avoided in cross-flow filtration where the flow sweeps the membrane surface 
clean. 
For dead-end filtration the thickness of the solids build up increases and the permeate flux 
decreases with time, ultimately reaching zero. In cross-flow filtration the feed can contain either 
a soluble or a solid solute, which becomes concentrated at the membrane surface; the permeate 














Figure 3.6 Schematic diagrams for (a) dead-end or conventional filtration and (b) cross-flow 
filtration. (Cross flow filtration adapted from Maja 2008) 
 
3.3.5 Membrane fouling 
 
Darcy’s law can be used to estimate filtration resistance of the membrane: 
 


















Where, J is the permeate flux (L/m
2
h), TMP is the transmembrane pressure (N/m
2
), and ε is the 
permeate viscosity (N·s/m
2
), Rt the total filtration resistance (m
-1
), and Am is the membrane area 
(m
2
), V is the volume of the permeate (m
3
), t is  the time (s). Generally, the flux tends to decrease 
due to fouling and concentration polarization over time. Many models describing permeate flux 
decline have been developed. The resistance-in-series model explains the permeate flux decline 
caused by various filtration resistances including concentration polarization, and cake layer: 







                                                         Equation 3.2 
Where the total filtration resistance Rt is composed of each filtration resistance caused by the 
membrane Rm, the irreversible fouling (Ri) and the reversible fouling (Rr). The irreversible 
fouling constitutes the fouling removed by chemical cleaning. The reversible constitutes the 
fouling removed by water cleaning. During filtration, particles are transported to the membrane 
surface by permeation drag. Concentration of peptides on the membrane surface reaches its 
maximum value after a short initial filtration and then the gel and cake layer starts to form. Rm 








3.4 Characterization techniques 
3.4.1 Peptide concentration 
 
This method is based on the derivatization of the protein with o-phthalaldehyde (OPA), which 
reacts with the primary amines of the protein (i.e., NH2-terminal amino acid and the α-amino 
group of the lysine residues). The sensitivity of the test can be increased by hydrolyzing the 
protein before it is tested. Hydrolysis makes the α-amino group of the constituent amino acids of 
the protein available for reaction with the o-phthalaldehyde reagent. The method requires very 




Figure 3.8 Chemical reaction of OPA assay 
3.4.2 Hydrophobicity 
 
The number, type and distribution of non-polar amino acid residues with the peptide determine 
its hydrophobic character.  A separation method that is based on the hydrophobic character of 
peptides is hydrophobic interaction chromatography.  
The high performance liquid chromatography (HPLC), especially at the reverse phase mode (RP-
HPLC), showed to be efficient to separate peptides from protein hydrolysates and also to give 
some indications about their hydrophylicity and hydrophobicity (Lemieux et al., 1991) Some 




peptides from tryptic hydrolysates of casein, from β-lactoglobulin A, and the human growth 
hormone (Kalgahati & Horvath, 1987; Maa & Horvath, 1988). 
The RP-HPLC was used to monitor the peptides produced at different stages of the hydrolysis 
process of whey proteins with commercial proteinases (Perea et al., 1993). Imbert & Nicolas 
(1993) proposed a technique of RP-HPLC for separating the two peptides obtained from κ-casein 
hydrolysis by rennet, A and B caseinomacropeptides, which are important for identifying the 
adulteration of milk or milk powder with whey. Also, RP-HPLC technique has been shown 
useful in separating active peptides from protein hydrolysates. Thus, the separation of a bioactive 
peptide prepared by a continuous hydrolysis of β-casein in a membrane reactor was carried out 
by RP-HPLC (Bouhllab et al., 1993). The elution profiles on a RP-HPLC column was also used 
in a collaborative study about the antioxidative activity of peptides from protein hydrolysates 
(Chen et al., 1995). Another utilization of RP-HPLC technique in protein hydrolysates analysis is 
related to the identification of the specificity of different proteases. Thus, the characteristic RP-
HPLC patterns of k-casein cleavage were shown to be useful for characterizing the types of 




Figure 3.10 Principal of RP-HPLC with compounds 
Reversible hydrophobic interaction between amino acid side chains on the peptide with the 




3.4.3 Aggregation  
 
Each peptide has a distinct and characteristic solubility in a defined environment and any 
changes to those conditions (buffer or solvent type, pH, ionic strength, temperature, etc.) can 
cause peptides to lose the property of solubility and precipitate out of solution. The environment 
can be manipulated to bring about the separation of peptides. 
The objective of this work was to characterize the change in peptide solubility resulting from 
changing some physicochemical conditions in non-animal media supplements. Groleau 2003 was 
previously demonstrated that peptide-peptide interactions occured in a β-lactoglobulin (β-LG) 
tryptic hydrolysate, mainly driven by hydrophobic interactions, and that some peptides 
aggregated at acid pH. The aggregation of peptides during enzymatic hydrolysis of whey 
proteins has been observed in several studies (otte et al, 1997) in which aggregates were shown 
to consist of peptides of 2-6 kDa, predominantly linked together by non-covalent interaction. 
Groleau 2003 was undertaken to characterize peptide aggregates formed in a tryptic hydrolysate 
of β-LG under different physicochemical conditions, and to demonstrate the occurrence of 
peptide-peptide interactions in a peptide mixture. Turbidity (500nm) was used as a tool to follow 
the aggregation process, and peptide aggregates were isolated and identified by chromatography. 
The turbidity (500nm) of a 1% solution of tryptic peptides was measured at pH 3- 10, at 5, 25,50 
C, in the presence of different salt concentrations (0, 0.5 and 1 M NaCl) in the presence of 
denaturing and reducing agents (6M urea, 5% SDS, or 5% β-mercaptoethanol), and under an 
electric field (isoelectric focusing).  
 
3.4.4 Total antioxidant Capacity 
 
Total antioxidant capacity works by measuring the amount of the substance being tested needed 
to inhibit the oxidation of the reagent. The reagent therefore measures the total reducing capacity 





On the basis of the chemical reactions involved, major antioxidant capacity assays can be 
roughly divided into two categories: (1) hydrogen atom transfer (HAT) reaction based assays and  
(2) single electron transfer (ET) reaction based assays. The ET-based assays involve one redox 
reaction with the oxidant (also as the probe for monitoring the reaction) as an indicator of the 
reaction endpoint. FCR assay is one of ET-based assays. Most HAT-based assays monitor 
competitive reaction kinetics, and the quantitation is derived from the kinetic curves. ORAC 
assay is one of HAT-based analysis. HAT-based methods generally are composed of a synthetic 
free radical generator, an oxidizable molecular probe, and an antioxidant. HAT- and ET-based 
assays are intended to measure the radical (or oxidant) scavenging capacity, instead of the 
preventive antioxidant capacity of a sample. Because the relative reaction rates of antioxidants 
(or substrates) against oxidants, particularly peroxyl radicals, are the key parameters for 
sacrificial antioxidant capacity, we will analyze antioxidation and its inhibition kinetics before 






Chapter 4 Materials and Methods 




 Yeast extract (No.211929, BD bionutrients, Mississauga), Difco
TM
 TC yeastolate 
(Cat.No.255772, BD bionutrients, Mississauga) and primatone were obtained from Becton 
Dickinson (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). Yeast extract (YE), 
yeastolate (YET), and primatone RL (PRI) were dissolved in deionized water (resistivity ~17.5 
MΩ: Millipore Milli-Q system, Etobicoke, Canada). Each solution (100mL) containing 1% (w/v) 
of either YE, or YET, or PRI was stirred for 5 min prior to ultrafiltration. The pH of the solution 
was measured before ultrafiltration (2±16 pH, EW-35610, Cole-Parmer, Montreal, Canada). 
4.2 Dead-end Ultrafiltration  
 
Unstirred dead-end ultrafiltration was performed using an Amicon ultrafiltration cell (model 
8200, Amicon Inc., Beverly, MA, USA), as in Figure 4.1. The maximum volume of 
ultrafiltration cell is 200ml and membrane area is 28.7
2cm . The total volume of the feed was 
specific to the filtration step (Figure 4.2). Three types of membrane MWCO were used in this 





Figure 4.1 Schematic diagram of dead-end ultrafiltration experimental set-up 
 
The 50kDa membrane was made of polyethersulfone (PES) (Omega Pall Corporation, 
Mississauga, Canada) and supplied as a flat sheet. The 3kDa and the 1kDa MWCO membranes 
were made of regenerated cellulose (RC) (Millipore Amicon Bioseparations, Etobicoke, Canada) 
and supplied as pre-cut membrane. The chemical structure of ployethersulfone and regenerated 
cellulose is shown in Appendix A. The sequence of the ultrafiltration is illustrated in Figure 4.2.  
Before each filtration, a new  membrane was soaked in Nanopure water (resistivity ~17.5 MΩ-
cm, Millipore Milli-Q system, Etobicoke,  Canada) for 90 min with the skin (glossy) side down, 
and the water was changed three times to remove the glycerin coating (which was added by the 
manufacturer to prevent drying.) The water flux was measured as a function of transmembrane 
pressure, and used to calculate the membrane resistance (Rm) as shown in Appendix B. After 
measurement of the water flux, the feed solution was placed in the UF cell and the filtration was 
started under constant transmembrane pressure of 40 psi (276 kPa) at room temperature. Each 
filtration had different initial concentrations and volumes, and a final retentate volume and 
volume concentration ratio (VCR=Vfeed/Vretentate) as indicated in Table 4.1. The mass of permeate 
was measured by an electronic balance (Adam Equipment Inc., Danbury, CT, USA), which was 




Table 4.1 Summary of volume and VCR for each ultrafiltration step 
 50 kDa MWCO 3  kDa MWCO 1 kDa MWCO 
Feed 100ml 90ml 60ml 
Retentate 10ml 30ml 30ml 
Permeate 90ml 60ml 30ml 









4.3 Total solids 
The total solids content (water-soluble and non-water soluble components) of YE, YET, and PRI 
feed and fractions was determined by freeze drying of a prescribed volume of sample.  
Freeze drying was carried out in a lab scale freeze dryer (Thermo savant super modulyo Edwards 
pirani 501, Germany) equipped with rapid freezing and drying facilities. Permeate and retentate 
samples were pre-frozen with liquid nitrogen and freeze-dried under variable chamber pressure  
(15-5 Ⅹ10
-3 
mbar) and temperatures (-30-70˚ C). After freeze drying, each sample was weighed 
and the difference was reported as the solid contents for the corresponding sample volume. After 
measuring the solids mass, the freeze-dried samples were sent to University of Manitoba for their 
evaluation as CHO cell media supplements.   
 
4.4 Total Peptide Content (OPA) 
 
This method is based on the derivatization of the peptide with o-phthalaldehyde (OPA), which 
reacts with the primary amines of the peptide (i.e., N-terminal amino acid and the α-amino group 
of the lysine residues). The method requires very small quantities of the peptides.  
Phenyl-Glycine solutions were prepared by dissolving Phenyl-Glycine (Sigma Aldrich, 
Mississauga, Canada) to concentrations 0, 250,500,750,1000mM in MilliQ water. A calibration 
curve was obtained with the above 5 Phe-Gly concentrations and was used to estimate the Phe-
Gly equivalent concentration of a given sample. 
Each sample solution contained 1.0wt/v% of lyophilized fractions which was within the range of 
the concentrations of the standard solutions. Deionized water was used as blank. 
An OPA solution was prepared by dissolving 0.08g of ortho-phthalaldehyde (Sigma, 
Mississauga, Canada) in 2 ml of ethanol, then adding 50 ml of 1.481g sodium borate buffer 




Scientific, Ottawa, Canada), 200 μL of ß-mercaptoethanol (Fisher Scientific, Ottawa, Canada). At 
this time, the pH of the OPA solution was adjusted to 9.0 with HCl of analytical grade. 
A prescribed volume (100 μL of Phe-Gly standard solution or 10 μL of test solution) was mixed 
with 1ml of OPA solution for 2min at room temperature. The absorbance of the final solution 
placed in a 1.5ml polymethyl methacrylate (PMMA) cuvette, was measured at 340nm and at 
room temperature (23±2℃), with a Cary 1 biosepectrophotometer (Varian, Winnipeg, Canada). 
 
The relationship between the absorbance (intensity) and Phe-Gly concentration was linear for the 
above concentrations and was used to estimate the total peptide concentration of the sample. An 
example of a calibration curve and a sample calculation is presented in Appendix C. 
Each assay was performed four times and a standard error (SE) was calculated for each data set.   
4.5 Antioxidant capacity 
 
The antioxidant capacity of the fractions was determined according to the FCR (Folin-Ciocalteu 
reagent) method (Stevanato et al 2004) with some modifications.  
Trolox (0.0254g) was dissolved in ethanol (20mL) to make a standard solution. Portions of this 
trolox solution were diluted with the deionized water to obtain not fewer than five standard 
solutions with concentrations between 1-3mM and evenly spaced (Above 3mM, the calibration 
curve was non-linear). 
The samples (1%wt/v) were dissolved in deionized water such that the antioxidant capacity 
would fall within the range of the concentrations of the Trolox standard solutions.  
Deionized water was used as blank.  
In a 4.5 volume PMMA cuvette, an aliquot of 20 μL of the sample to be analyzed or of the trolox 
solutions was added in series, 150 μL of Folin-Ciocalteu reagent (F5252, Sigma, Mississauga, 
Canada), 600 μL of Na2CO3 solution, and 2230 μL deionised water. After 2 hr incubation at room 




antioxidant capacity, expressed as a trolox equivalent (TE), was determined from the Trolox 
calibration curve.  An example of calculation and calibration curve is presented in Appendix C.  
 
4.6 Reversed-Phase (RP) HPLC 
 
RP-HPLC analyses were performed using a HPLC system Varian (Mississauga, Canada) 
consisting of an injector, two pumps (Prostar 210 solvent module), a column heater (#4774, 
Biorad, Mississauga, Canada), auto sampler (module 410, Varian, Mississauga, Canada), and a 
UV/Visible detector (Prostar 325 UV-vis detector, Varian, Mississauga, Canada) adjusted at 
214nm. The characteristics of the column are presented in Table 4.2. Data acquisition and 
analysis were done using the Prostar Chromatography software (version 6.0). The samples were 
analyzed with a symmetry® C18 column (3.9 x 150 mm, 5μm particle size, 100 Å pore size, 
Waters, Mississauga) at 45℃.  
Elution was carried out with a gradient formed between the mobile phase A (N2HPO4 buffer, 
adjusted to pH 6.9 with ortho-phosphoric acid) and the mobile phase B (acetonitrile 60 v/v %). 
The following elution program was used: 0.1% mobile phase A increased to 4% over 20min at a 
flow rate of 1 ml/min; the injected samples were monitored at a 214nm wavelength. The sample 
volume injection was 10 μL. 
The mobile phase was passed through a 0.2μm filter (cat 73520-996, Nalgen, Mississauga) and 
sonicated for degassing before use. Samples 1 % (wt/v) were prepared in the mobile A phase and 
filtered through 0.2 μm super® membrane low protein binding filters (PN 4602, life science, 




















Waters 3.9 X150 5 100 
B Luna 3u C18(2) Phenomenex 4.60X 100 3 100 
4.7 Aggregation 
 
A 10 %wt/v feed solution of YE, YET, and PRI was prepared with 1.01 g of feed and 10 mL 
water and the pH was adjusted to 4.0 with 1N HCl in order to induce acid aggregation. The 
solution was allowed to rest for 90 min at room temperature and then centrifuged at 329728.4 X 
g (Thermo WX Ultra 100, Missisauga) for 3hr (4°C) and the precipitate separated and 
lyophilized. 
   
The peptide aggregation was calculated as: 
 
Aggregate % = 100 ∗  
C𝑖−C𝑓
C𝑖
                                                                     Equation 4.1 









4.8 CHO cell growth enhancement 
 
4.8.1 CHO Cell culture 
 
CHO cells (beta-IFN producers) were inoculated at 10
5
 cells/ml into 4 ml of medium contained 
in a 25 cm
2 
T-flask. The basal medium (Biogro-CHO) was supplemented with the feed (crude-
YE, YET, PRI) and its corresponding fractions (50kDa-re, 3kDa-re, 1kDa-re, and 1kDa-per) as 
will be detailed in section 4.8.3.  Samples (0.1 ml) were removed each day for cell counting.  
Cultures were routinely maintained over 4 days.  After that the cell viability decreased 
significantly. The work was conducted at University of Manitoba.  
4.8.2 Cell counting 
 
Culture samples were treated with 0.2 % trypan blue, (1:1 v/v) and the viable cells (unstained) 
were counted with a haemocytometer.  
 
4.8.3 Growth enhancement assay 
 
This was based upon the dependence of CHO growth on the feed hydrolysate (YE, YET, PRI) 
concentration in the Biogro-CHO basal medium.  Conditions were selected such that growth was 
concentration dependent for crude non-fractionated YET. Briefly summarized (data not shown), 
the addition of YET up to 0.05% (w/v) to CHO cultures resulted in a concentration-dependent 
enhancement of cell growth.  No growth was obtained in the absence of crude non-fractionated 
YET. Maximum cell yields were obtained at 0.05% (w/v) YET. The growth enhancement was 
consistent and reproducible over 5 culture passages. The cell yield was reduced to 50% 




At 0.05% (w/v) hydrolysate supplement, the growth of cells was over x 2 that at a concentration 
of 0.025% (w/v).  As a consequence, fractions were tested by addition to the 0.025% (w/v) feed-
supplemented media.  Specific fractions were added to media containing the crude feed 
hydrolysate (0.025% (w/v)) of the same type. For example, Primatone fractions were added to 
media supplemented with the minimal levels of crude Primatone. A negative control consisted of 
the same volume of 0.025% (w/v) of the corresponding crude feed hydrolysate. The positive 
control consisted of the same volume of 0.05% (w/v) of the corresponding crude feed 
hydrolysate. The growth enhancement was normalized to compare between sample sets. 
% growth enhancement = (X – N)*100/ (P – N)                                        Equation 4.3 
Where:  X  = Cell yield of sample 
        N = cell yield of negative control 
           P = cell yield of positive control 
 
4.9 Statistical Analysis 
 
The membrane lot to lot variability of 3kDa and 1kDa, membrane resistance was assessed at p= 
0.05. The peptide contents and antioxidant capacity of the feed and the fractions with and 
without freeze-dring were compared using a two-tailed t-test as described by Montgomery 2001 




Chapter 5 Sequential Membrane Ultrafiltration Fractionation 
 
The volumetric permeate flux Jv, the volumetric filtration rate per unit membrane surface area 
and time expressed in L/m
2
·h, represents the productivity of a membrane separation process. In 
typical ultrafiltration system operated at constant transmembrane pressure, the permeate flux will 
be affected by the following factors: properties of the membrane, the transmembrane pressure, 
the system hydrodynamics and the feed properties (concentration, composition, ionic strength, 
pH and size distribution). The characteristics of the fractions obtained for different membrane 
types and feed will be discussed with the objective of producing fractions with improved 
properties for the preparation of serum free medium supplements. Three different size-based 
membrane were characterized in section 5.1, permeate flux profile of each membrane with yeast 
extract (YE), yeastolate (YET), and primatone (PRI) in section 5.2. Fouling resistance analysis 
was investigated in section 5.3. The characterization of the freeze-dried fractions, total solids 
(5.4), total peptide concentration (5.5), antioxidant capacity (5.6) and hydrophobicity (5.7) will 
then be presented in the context of fractionation efficiency. 
 
5.1 Membrane Characterization 
 
The resistance of the clean membrane (Rm) was estimated and used subsequently to evaluate the 
fouling occurring during the filtration according to equation 4.2, and the method described in 
section 4.2. The global fouling resistance (Rg) was decomposed as the clean membrane resistance 
(Rm) and the total fouling resistance (Rt) according to equation 4.1. The resistance of the clean 
membrane measured with deionized water is presented in Table 5.1. The clean membrane 









±0.29, n=6), both are regenerated cellulose membranes. This also indicates 













, n=8). We did observe membrane to 
membrane variability between same-sized 3kDa membranes of the same manufacturer but from 









±0.1, n=3) were statistically different (p < 0.04, n=3). On the other hand, no 









±0.4, n=3). The effect of these clean membrane 
resistance differences on the permeate flux will be discussed in section 5.2. 
5.2 Permeate Flux Profile 
 
After measuring the clean membrane resistance (Rm) with DI water, each feed was subjected to 
the sequential ultrafiltration process, 50 kDa, 3 kDa and 1 kDa (Figure 5.1), and the permeate 
flux (Jp) recorded. The performance of each filtration step and different types of feed will be 
discussed in the next sections. 
5.2.1 Effect of membrane MWCO 
 
The effect of the membrane MWCO, obtained from the permeate flux, is presented for each feed 
type in Figure 5.1. In general, a similar behavior was observed for all three feed types 
investigated in this study and a given filtration step. As expected, the permeate flux was much 
faster for the 50 kDa compared to both the 3 and 1 kDa membrane. For the 50 kDa filtration, the 
volume of the feed solution was 100 ml and the filtration was stopped when 90mL of permeate 
had been collected corresponding to VCR=10. The highest permeate flux, observed over the 
course of the filtration with the 50 kDa membrane (1600-50 L/m
2
·h), indicated limited 
membrane fouling and limited retention of feed components. The total time for the filtration for 
all three feeds with the 50 kDa membrane was less than 20 minutes. The permeate flux for the 3  
kDa and 1 kDa membrane was much lower for all three feeds (20-5 L/m
2
·h) and the filtration 




which indicates that fouling was occurring during the entire filtration operation. In contrast, a 
relatively constant permeate flux over time was observed for the filtration with the 1 kDa (5~8 
L/m
2




Figure 5.1 Permeate flux in unstirred dead-end sequential ultrafiltration at 276kPa and room 
temperature: A) YE (50kDa (+), 3kDa (□), and 1kDa (■) membrane); B) YET (50kDa (+), 3 
kDa(Δ), and 1kDa(▲) membrane); C) PRI (50 kDa (+), 3kDa (○), and 1kDa (●) membrane); 




5.2.2 Effect of feed type 
 
Figure 5.2 presents the effect of the feed type on the permeate flux for the 50 kDa membrane and 
VCR=10. YE and PRI had a similar permeate flux profile. In contrast, the permeate flux 
behavior for YET remained higher during the entire filtration in comparison to YE and PRI 
which is suggesting different fouling behavior and feed properties. 
 
 
Figure 5.2 Permeate flux in unstirred dead-end ultrafiltration by 50kDa MWCO membrane to 
VCR 10: □ YE, Δ YET, and ○ PRI, 1wt% feed solution, initial volume 100ml, 276kPa  at room 
temperature. 
 
The permeate flux as a function of time for the 3kDa ultrafiltration of three feed types is shown 
in Figure 5.3. The initial feed solution was the permeate collected during the 50kDa filtration (90 
mL). The filtration was stopped when 60mL of permeate had been collected corresponding to 
VCR=3. The flux increased initially (to 20 L/m
2
·h), due to the pressurization of the cell to 276 
kPa, followed by a rapid flux decline (to 10 L/m
2




flux decrease until the end of filtration. The final flux was approximately 7.5 L/m
2
·h (YE) and 
8.7 L/m
2
·h (YET), both lower permeate flux than for PRI (11 L/m
2
·h). Champagne et al (1999) 
has shown that permeate flux of YE 10% (w/v) was 50 L/m
2
·h operated by tangential filtration 
system with 3kDa MWCO. The permeate flux is higher than this study because of the tangential 




Figure 5.3 Permeate flux decline in unstirred dead-end ultrafiltration to VCR 3 using the 3 kDa 
membrane (Lot A): □ YE, Δ YET, and ○ PRI. Conditions: initial volume 90ml, 276kPa at room 
temperature. 
 
The permeate flux for the 1kDa ultrafiltration of YE, YET, and PRI as a function of time is 
illustrated in Figure 5.4. The permeate flux remained relatively constant for the three types of 
feed solutions but at different permeate flux values. The filtration of YET took longer than YE 
and PRI because the permeate flux was ~5-6 L/m
2
·h for YET compared to ~7-8 L/m
2
·h for YE 








compared to the YET and PRI filtrations. Theoretically the lowest Rm values should give the 
highest flux rate; however, this was not observed for these experiments. Champagne et al (1999) 
has shown that permeate flux of YE 10% (w/v) was 30 L/m
2
·h operated by tangential filtration 




Figure 5.4 Permeate flux in unstirred dead-end ultrafiltration with 1 kDa membrane (Lot A) and 
















Figure 5.5 Permeate flux in unstirred dead-end ultrafiltration of 3KDa a) lot A  b) lot B : □ YE, 
Δ YET, ○ PRI to VCR 3 , conditions: initial volume 90ml, 276kPa at room temperature. 
 
The variability of the clean membrane resistance for the 3kDa membrane (identified from the 
measurements of the clean membrane resistance (section 5.1)) affected the permeate flux as 
illustrated in Figure 5.5. The contribution of this initial variability can be removed by looking at 
the normalized permeate flux, ie permeate flux at time t (Jp)/initial permeate flux at t=0 (Jo).  
This approach was able to eliminate the membrane variability between different membrane lots 






Figure 5.6 Permeate flux in unstirred dead-end ultrafiltration of 3kDa of YE, YET, PRI;  A) □ 
YE lot A,■ YE lot B, B) ΔYET lot A, ▲ YET lot B, C) ○PRI lot A, ●PRI lot B to VCR 3 , 
conditions: initial volume 90ml, 276kPa at room temperature. 
 
In contrast, the permeate flux profile of 1kDa was similar for membranes of different lots since 






Figure 5.7 Permeate flux in unstirred dead-end ultrafiltration of 1kDa A) lot A B) lot B : ■ YE, 
▲ YET, and ● PRI to VCR 2, conditions: initial volume 60ml, 276kPa at room temperature.  
 
 
5.3 Fouling resistance analysis 
 
To investigate whether the membrane fouling was caused by the different feed solutions and 
membrane MWCO, the global and individual fouling resistances were estimated and are reported 
in Table 5.1 for filtrations performed in duplicates. 
The ratio of the sum of the reversible and irreversible fouling resistances to the membrane 
resistance was selected as an indicator of the relative fouling occurring during the filtration. The 
ratio is about 2 for YE and YET and the 3kDa membrane MWCO, an indication of the 
significance of fouling.  In contrast, this ratio was 1.46 for PRI. For the 1kDa membrane 
MWCO, the ratio was ~1 or less which indicates that fouling was not significant when compared 





Table 5.1 Global fouling resistance (RG) evaluated from Eq. 3-2 with the contribution of 
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3 8.65 ± 0.5 13.1Ⅹ1013 4.68Ⅹ1013 8.45Ⅹ1013 2.02 
1 7.26 ± 0.07  15.4Ⅹ1013 8.34Ⅹ1013 7.02Ⅹ1013 0.84 
YET 
3 9.08 ± 1.0  12.5Ⅹ1013 4.15Ⅹ1013 7.02Ⅹ1013 2.03 
1 6.06 ± 0.1  18.5Ⅹ1013 9.44Ⅹ1013 9.06Ⅹ1013 0.96 
PRI 
3 11.72 ± 1.6  10.2Ⅹ1013 4.09Ⅹ1013 6.12Ⅹ1013 1.46 
1 7.83 ± 0.04  14.2Ⅹ1013 9.36Ⅹ1013 4.88Ⅹ1013 0.52 
*Measured at the end of the filtration, n=2; mean +standard error 
5.4 Total solids  
 
Total solids analysis of the different streams provided information on the retention and 
correspondingly permeation efficiency of the filtration. The total solids content for 50, 3, and 1 
kDa retentate and permeate is presented in Table 5.2. The three types of feed have similar total 
solids content recovered in the 50 kDa retentate fractions, ~14% of the initial solids of the feed 
stream. The distribution of total solids content differered for the subsequent 3 kDa and 1kDa 
fractionation steps. YE and YET were relatively similar, with equal distribution of total solids in 
the 3 fractions: fraction 1 (< 50kDa but > 3kDa), fraction 2 (< 3kDa but > 1kDa), fraction 3 (< 
1kDa). In contrast, Primatone contained 14% total solids (< 50kDa but > 3kDa), 29% (< 3kDa 
but > 1kDa) and 33% (<1 kDa). The lower total solids content for PRI and fraction 1 (< 50kDa 




total solids content of fraction 2 (< 3kDa but > 1kDa) is also reflected in the higher global 
fouling observed during the filtration. 
 
Table 5.2 Mass of total solids in feed and fractions, mean ±SE (n=2) 
  
5.5 Total peptide content 
 
The total peptide content was estimated by the OPA assay as equivalent Phenyl Glycine (Phe-
Gly). The total peptide content was evaluated for fresh and freeze-dried samples. There was no 
statistically significantly effect of freeze-drying on the Phe-Gly content (data not presented).  
Therefore the total peptide content is reported for the fresh samples in Tables 5.3 a, b, c. The 
feed had different equivalent Phe-Gly content for a similar total solids content.  Yeast extract 
(YE) contained the highest amount of equivalent Phe-Gly which is statistically different than 
YET and PRI (p<0.05). In spite of different feed equivalent Phe-Gly, all three feeds contained a 
similar amount of equivalent Phe-Gly with molecular weight larger than 50 kDa, 15-19% of the 
initial feed stream. This was a similar amount as the total solids content presented in Table 5.2. 
The total peptide content of the retentate obtained for the 3kDa filtration indicated that YE and 
YET contained ~ 20% of equivalent Phe-Gly larger than 3 kDa but smaller than 50kDa. In 
contrast, PRI contained only 6% of equivalent Phe-Gly with such molecular weight. The 


















YE 1.01 0.13±0.03 0.26±0.05 0.19±0.08 0.22±0.01 0.21 
YET 1.01 0.15±0.02 0.22±0.04 0.24±0.01 0.28±0.01 0.12 




for YE and 38% for YET (p< 0.05).  Looking at the absolute content for each fraction and feed, 
the distribution according to molecular weight is summarized in Table 5.3 d. All three feeds have 
similar total peptide content smaller than 1 kDa. Differences are observed for all other fractions. 
But for any given feed, the equivalent Phe-Gly larger than 1 kDa but smaller than 3 kDa 
predominated. The total peptide content profile according to size coincides with the total solids 
distribution for all three feed types. This is the first study that reports on the total peptide content 
for YE, YET, and PRI subjected to ultrafiltration fractionation Indeed, different methods were 
used to assessed the α-Amino nitrogen (6g/100g of Total solid) and total nitrogen (10g/100g of 
Total solid) of the YE and fractions produced by tangential flow ultrafiltration were determined 
by titration following reaction with formaldehyde (Gaudreau et al, 1999). 
 












YE 413.7±22.5 78.5±3.5 298.6±10.5 37 19 72 
YET 303±8 47.5±1.5 262±3 6 15 86 
PRI 330.1±1.6 62.7±0.5 267.2±2.9 1 18 80 
* Phe-Gly (mmol) retentate/ Phe-Gly (mmol) feed 












YE 298.6±10.5 82.8±3.5 215.7±12.0 1 20 72 
YET 262.3±3.0 56.0±0.5 210.5±1.0 4 21 80 
PRI 267.2±2.9 18.7±0.15 242.9±2.2 7 6 90 
















YE 216±12 101±3 112.6±3.0 2 47 52 
YET 210.5±1 81±1 111.4±0.3 19 38 52 
PRI 243±2 134.7±0.7 98.6±10.4 10 55 40 
* Phe-Gly (mmol) retentate/ Phe-Gly (mmol) feed 
Table 5.3 d Equivalent Phe-Gly content distribution according to molecular weight, fresh 



































































5.6 Total antioxidant capacity  
The antioxidant capacity of YE, YET, and PRI was measured by Folin-Ciocalteu’s reagent 
(FCR) assay using 6-hydroxy-2,5,7,8-tetramethylchloroman-2-carboxylic acid (trolox) as a 
standard. The analysis conducted for fresh and freeze dried samples is presented in Table 5.4.  
The total antioxidant capacity of YE, YET, and PRI ranged from 30 mg Trolox/g sample (YET 
1kDa permeate) to 60 mg Trolox/g sample (YE 1kDa retentate), which are significantly different 
(p < 0.05). From the statistical analysis, freeze dried sample has a higher antioxidant capacity 
than fresh sample which is significantly different (p < 0.05) for all the YE fractions , the 50 kDa 
and 1 kDa fractions of  YET and the 50 kDa, 3 kDa permeate and 1 kDa permeate for PRI. These 
results indicate that the antioxidant capacity will generally maintain for prolonged time, with 
freeze drying treatment.   
When considering the freeze-dried samples, no real enhancement was observed as a result of 
ultrafiltration fractionation.   
 
Table 5.4 Total antioxidant capacity of fresh and freeze dried fractions.   Mean + SE (n=4). 





g  sample] 
3kDa-re  
[mg Trolox/ 








Fresh  49.2 ± 8.1 49.9± 9.2 56.2± 1.1 61.8± 1.9 41.3± 2.2 
Freeze 
dried 
51.6 ±0.9 50.4± 2.6 46.9± 0.7 49.3± 1.8 47.8± 0.5 
YET 
Fresh  54.3 ± 1.6 50.1± 1.2 38.7± 8.3 44.6± 1.7 31.6± 1.4 
Freeze 
dried 
42.8 ± 1.5 45.9± 2.4 44.1± 0.9 49.4± 0.4 45.9± 0.6 
PRI 
Fresh  55.2 ± 0.6 45.3± 3.9 50.7± 7.0 56.8± 1.0 47.4± 2.2 
Freeze 
dried 




There are a number of publications on the assessment of antioxidant capacity with different 
standards (garlic acid), assays (FCR, ORAC) and food products (wine, soy, sprout, onion, fruits) 
(Paixao 2007, Martin 2000, Wang 1996, Zielinska 2008). From the production of antioxidant 
capacity in YE and YET, they carefully controlled to preserve the naturally occurring B-complex 
vitamins and other vitamin mixture (Sommer 1996)  
 
5.7 Hydrophobicity analysis by RP-HPLC 
The relative hydrophobicity of the peptides and amino acids contained in feed, permeate, and 
retentate fractions was analyzed with Reversed Phase High Pressure Liquid Chromatography 
(RP-HPLC). The retention time gives a relative measure of the hydrophobicity of substances 
contained in a mixture. A procedure was first developed to identify the most suitable absorbance 
wavelength for detection and column for the separation of the components contained in samples 
without any pretreatment. 
A comparison of the absorbance for YE feed solution was performed to identify the most 
appropriate wavelength for detection (Figure 5.8). Absorbance was observed at two wavelengths, 
210 and 260 nm.  From literature, ~260nm is used to detect protein while ~210 nm is used to 
detect small molecules such as amino acids or peptides (Tessier 2006). The next step was the 
comparison of the absorbance profile at 260 nm and 214 nm for YE separated with a C18 
column (Figure 5.9). The absorbance at 214 nm provided a better more detailed resolution than 
the absorbance at 260 nm. The presence of a peak at 214 nm, near 210 nm, reflects small 
molecules which are of interest in this study and confirmed the choice of absorbance wavelength 
selected at 214 nm.  
The next step was to investigate two types of columns. A mixture containting 5 different amino 
acids with different hydrophobicity characteristics (Alanine, Glycine, Tyrosine, Phenylalanine, 
and Tryptophan) was selected for this analysis(Figure 8.2 and 8.3 Appendix C). Only three of the 
five amino acids were resolved for both types of column investigated, C18 and C8. Alanine and 




was reduced to three amino acids, tyrosine, phenylalanine and tryptophan and was used to 
analyze the chromatogram of YET (Figure 5.10). The retention time of the three individual 
amino acids when compared to the absorbance profile of YET feed (Figure 5.10) shows that 
YET contain Tyr, Phe, and Trp.  
The hydrophobicity of each feed solution is illustrated in Figure 5.11 where three major peaks 
are identified for YE and YET and two major peaks for PRI. 
The absorbance profile of the feed and the 1 kDa retentate and permeate fractions illustrated in 
Figure 5.12 does not reveal major differences for a given type of feed. This indicates that RP-
HPLC of the untreated samples was unable to provide information on the relative hydrophobicity 
of the fractions.   
 
 







Figure 5.9 Chromatogram of YE feed solution with RP-HPLC C18 Column and detection  at 





Figure 5.10 Comparison of the elution profile: Mixture of three amino acids (Tyrosine, 
Phenylalanine, and Tryptophan) and YET feed (component B; 1 % wt/v) with C8 column and 
detection at 214nm. 
 
Figure 5.11 Comparison of YE, YET, and PRI feed (1% wt/v) analyzed by RP-HPLC C18 and 





Figure 5.12 Comparison of the relative hydrophobicity for YE (A), YET (B), and PRI (C) feed 
and the corresponding 1 kDa fractions (1% w/v) with RP-HPLC C18 column and detection at 
214 nm 
5.8 Aggregation  
The potential of acid precipitation to remove hydrophobic peptides contained in YE, YET and 




precipitation indicating that these feed contain a very small amount of hydrophobic peptides. 
This is quite small amount of aggregation than Shen 2007 work.   
 
 55 
Chapter 6  CHO cell growth enhancement  
In this chapter, the bioactivity of freeze-dried fractions obtained from YE, YET, and PRI 
subjected to different membrane ultrafiltration conditions (50, 3, and 1 kDa) is reported. The 
bioactivity was measured as cell density for CHO (beta-IFN producers) cell line cultured in T25 
flasks with basal medium (Biogro-CHO) containing 0.025% of the fraction added to 0.025% of 
the corresponding crude non-fractionated feed hydrolysate. A negative control consisted of the 
same volume of 0.025% (wt/v) of the corresponding crude non-fractionated feed hydrolysate. 
The positive control consisted of the same volume of 0.05% (wt/v) of the corresponding crude 
non-fractionated feed hydrolysate.. The work was conducted at University of Manitoba. . 
 
6.1 Primatone  
 
In Figure 6.1 the CHO (beta-IFN producers) cell line cultured in basal medium (Biogro-CHO) 
supplemented with crude non-fractionated PRI (0.025 % wt/v) achieved a cell titre of about 
124x10
4
 cells/ml which corresponds to the negative control. The positive control, the addition of 
crude non-fractionated PRI (0.05% wt/v), increased the maximal cell density by a factor of 
almost 2-fold. At day four, all four PRI fractions enhanced cell growth significantly compared to 
the negative control.  However, there was no significant difference between the cell density for 
the four different types of PRI fractions.   
 The similar growth enhancement effects of the four fractions can not be linked to the differences 
of the  total peptide content or the total peptide content/ mass of total solids (Table 5.3d), . For 
example, the 3kDa retentate has the lowest total peptide content (18mmol PheGly equivalent and 
134 mmol PheGly equivalent/g total solids) while the 1kDa retentate (134mmol PheGly 
equivalent and 464 mmol PheGly equivalent/g total solids) has the highest total peptide content. 
A relationship exists for the similar cell growth enhancement of the four fractions and their 
similar antioxidant capacity (~45 mg Trolox/ g sample) and hydrophobicity analyzed by RP-




maximum cell density of the negative control and the maximum cell density  normalized with the 
two controls  according to equation 4.3, 38.9, 40.2, 34.5 and 45.7 % for the fraction larger than 
50 kDa, the fraction smaller than 50 kDa but larger than 3 kDa, the fraction smaller than 3 kDa 




Figure 6.1 CHO cell  growth curve in the serum-free basal medium supplemented with crude 
non-fractionated PRI and PRI fractions ; 50kDa retentate (●), 3kDa retentate (○), 1kDa retentate 
(▼ ), 1kDa permeate(∇), Negative control 0.025% (wt/v) crude non-fractionated PRI (■), 
Positive control 0.05% (wt/v) crude non-fractionated PRI (□) , the mean (SE) of duplicate 
cultures at each of 3 culture passages (n=6). 







6.2 Yeast Extract 
 
The growth-promoting activity of YE and its fractions on CHO cells was tested in the basal 
medium ((Biogro-CHO) and compared to 0.025% (wt/v) of YE (negative control) and 0.05% 
(wt/v) of YE (positive control). Data in Figure 6.2 indicate that the growth of CHO cells in the 
basal medium with YE fraction (50, 3, and 1 kDa retentate and permeate) was very limited, and 
the maximum cell density was 217Ⅹ10
4
 cells/mL. The supplementation of the crude non-
fractionated YE promoted the cell growth, with cell density of 222 x10
4
 cells/ml for the negative 
control and cell density of 282 x10
4
 cells/ml for the positive control. The supplementation of YE 
fractions was less growth-promoting  compared to YE negative control suggesting that these 
fractions may contain growth inhibitory elements in higher amount than in the crude non-
fractionated YE.  One has to keep in mind that   the YE negative control (222 x10
4
 cells/ml) 
showed the  highest growth enhancement compared to the negative control for YET (122x10
4
 
cells/ml) and PRI (124 x10
4
 cells/ml). Further analysis would be required to confirm the growth 
effects of the negative control of YE.  
The similar low growth patterns of the different fractions could not be related to the different 
amounts of total peptide estimated in the various fractions (Table 5.3d). For example, the total 
peptide content for the fraction smaller than 50 kDa but larger than 3 kDa (318mmol PheGly 
equivalent/g total solids) and the 50kDa-re (604mmol PheGly equivalent/g total solids) was 
different but the cell density was the same. The growth behavior of the different fractions could 
be related to the similar antioxidant capacity measured, ~50 mg Trolox/ g sample.  
Previous study (Smith 1973) indicates that YE has small size of peptides which have potential 
growth ingredient. Also approximately 50% of amino acid is smaller than 3 kDa is occurs as 
important nutrients for vertebrate and invertebrate cells in culture. The concentration of free 
amino acids in a culture medium supplemented with wheat protein hydrolysate can differ during 
the growth phase (Hansen and Emborg, 1992).  
It was reported that peptides of plant protein hydrolysate exerted specific effects, growth or 




Sung et al 2004, of these additives (yeast hydrolysate, soy hydrolysate, wheat gluten hydrolysate 
and rice hydrolysate), YE was most beneficial to human thrombopoietin (hTPO) production, 
resulting in a more than 11-fold increase in the maximum hTPO concentration. Furthermore, cell 
viability during the culture using YE supplemented serum-free medium was higher than that 
using other medium tested (soy, wheat gluten, and rice hydrolysate) and thereby rCHO cells, 
liberating proteases and glycosidase from dead cells, was least significant.  
According to the production information provided by Quest International, total amino acid 
concentration in YE are not significantly different from those in other hydrolysate (wheat gluten 




Figure 6.2 CHO cell growth curve in the serum-free basal medium supplemented with YE and 
YE fractions ; 50kDa retentate (●), 3kDa retentate (○), 1kDa retentate (▼), 1kDa permeate (∇), 
Negative control 0.025% (wt/v) YE (■), Positive control 0.05% (wt/v) YE (□), the mean (SE) 








The growth-promoting activity of YET and its fractions on CHO cells is presented in Figure 6.3.  
The growth of CHO cells in the basal medium supplemented with 0.025% (wt/v) YET (negative 
control) was 122Ⅹ10
4
 cells/mL and the maximum cell density was 219 Ⅹ10
4
 cells/mL. The 
supplementation with crude non-fractionated YET (0.05% wt/v) or its fractions promoted the cell 
growth, and the maximum cell density was increased to  169, 144, and 135 Ⅹ10
4
 cells/mL 
respectively in the cultures supplemented with 3kDa retentate, 1kDa retentate, and 1kDa 
permeate respectively. No growth enhancement effect was observed with the addition of the 50 
kDa retentate. The cell growth-promoting effect of the added YET fractions is reflected by the 
cell density normalized with the two controls  according to equation 4.3, 48.6, 22.6 and 13.7 % 
for the fraction smaller than 50 kDa but larger than 3 kDa, the fraction smaller than 3 kDa but 
larger than 1 kDa and the fraction smaller than 1 kDa, respectively. 
 
The growth patterns of the different fractions obtained from YET could not be related to the 
different estimates of total peptide content (Table 5.3d). For example, the total peptide content 
for the fraction smaller than 50 kDa but larger than 3 kDa (255 mmol PheGly equivalent/g total 
solids) and the fraction smaller than 1 kDa (398 mmol PheGly equivalent/g total solids) were 
opposite to the effect of the growth enhancement. The growth behavior of the different fractions 







Figure 6.3 CHO cell growth curve in the serum-free basal medium supplemented with YET and 
YET fractions; 50kDa retentate (●), 3kDa retentate (○), 1kDa retentate (▼), 1kDa permeate (∇), 
Negative control 0.025% (wt/v) YET (■), Positive control 0.05% (wt/v) YET (□), mean (SE) of 
duplicate cultures at each of 3 culture passages (n=6). 
 
  
6.4 Comparison of the 1kDa ultrafiltation with PRI, YE, and YET 
 
As the published studies on the growth promoting effects of hydrolysates indicate that the small 
peptides are the most active, the fractions produced during the last ultrafiltration step with the 1 
kDa membrane for the three feed types will be discussed in this section. Figure 6.4a shows the 
growth profiles obtained by the supplementation of the 1kDa retentate factions from the three 
different sources.  The growth enhancement of the 1 kDa retentate is highest for YE, with PRI as 




the 1 kDa permeates from the three different sources.  The 1 kDa permeate from Primatone and 
yeast extract had a significantly higher growth enhancement effect than Yeastolate (p< 0.05). 
 
  
Figure 6.4 CHO cell growth curve in the serum-free basal medium supplemented with PRI, YE, 
and YET fractions; A) 1 kDa retentate: PRI (●), 1 kDa retentate YE (○), 1 kDa retentate YET 
1kDa (▼); B) 1 kDa permeate PRI (●), 1 kDa permeate YE (○), 1 kDa permeate YET (▼). Mean 




Considering all the fractions produced during the sequential ultrafiltration treatment, the relative 
CHO cell growth enhancement of the various fractions can be summarized as follows.  The 1 
kDa retentate and permeate fractions obtained from YET both showed lower growth when 
compared to the 3 kDa retentate. The relative growth enhancement of all four PRI fractions was 
high. The PRI 1 kDa permeate was the highest (45.7%). The relative growth enhancement of the 
3 kDa retentate was high for both PRI (40.2%) and YET (48.6%). There was no apparent growth 
enhancement for any of the YE fractions.  Note that the PRI positive control (261x10
4
 cells/ml) 
was higher than the YET positive control (219x10
4
 cells/ml) but lower than the YE positive 
control (282x10
4




feed material at the same concentration. These differences may have also contributed to the 






Chapter 7 Conclusions and Recommendations 
 
Enhancement of CHO cell growth by Yeast extract (YE), Yeastolate (YET), and Primatone (PRI) 
fractions with size-based ultrafiltration was investigated in this study. Three feed solutions (1% 
w/v) were prepared and subjected to sequential ultrafiltration (50kDa (polyethersulfone), 3kDa 
(regenerated cellulose), and 1kDa (regenerated cellulose)). Each filtration system was stopped at 
a specific volume concentration ratio (VCR), 10, 3, and 2, respectively.  The membrane 
resistance and the global membrane fouling resistance were investigated. Feed and fractions 
(retentate and permeate) were collected and freeze dried for testing their biological activity on 
CHO cells (beta-IFN producers) and  the total solids, total peptide content, antioxidant capacity 
and hydrophobicity were evaluated. Thermal stability was considered in peptide concentration 
and antioxidant activity by freeze-dry process. 









±0.29, n=6), as expected 1kDa membrane has 
higher resistance. For the 3kDa membrane, membrane to membrane variability of the same 
manufacturer was observed for different lots. The performance of the filtration for the three feed 
solutions and three membranes showed that the 50 kDa membrane has the highest permeate flux 
when compared to the 3 and 1 kDa membrane. The final permeate flux with the 3 kDa membrane 
of PRI (11 L/m
2
·h) was higher than YE (7.5 L/m
2
·h) and YET (8.7 L/m
2
·h). The permeate flux 
with the 1 kDa membrane was relatively constant over time and similar for all three feeds, 6~8 
L/m
2
·h. The membrane to membrane variability of the 3kDa membrane for two different lots 
was observed, however this difference did not affect the type of fouling mechanism. The 
difference between membrane lots could be removed by considering the normalized permeate 
flux. Overall, similar filtration behavior with some fouling during the UF 3kDa for YE, YET but 
different for PRI. 
The membrane fouling main factors were investigated by fouling resistance analysis. The ratio of 




selected as indicator. This ratio for YE and YET and the 3kDa membrane was about 2 which 
showed that fouling was the dominant factor. In contrast, 1kDa membrane filtration had a ratio 
less than 1 which indicated that fouling was not significant compared to the clean membrane 
resistance.   
The total solids and total peptide contents and the antioxidant capacity of the feed and the 
fractions were estimated.  YE and YET fractions possessed relatively similar profiles, with equal 
distribution of total solids in the size-based fractions. In general, the total peptide content 
measured as equivalent PheGly was ~37 %< 1kDa<~30 %< 3kDa<~25 %< 50kDa<~8 % of 
three materials approximately. The total antioxidant capacity of the freeze-dried samples was 
quite similar for all fractions, ~ 40-50 mg Trolox/g sample.  The hydrophobicity of YE and YET 
was similar but different than PRI. Differences in the hydrophobicity between the feed and the 
fractions could not be observed with the approach considered in this study where the samples 
were directly analyzed by reversed-phase HPLC. Finally, a negligible amount of hydrophobic 
components (1.5 wt %) could be removed by acid precipitation.  
The bioactivity of feed and fractions was measured as cell density for CHO (beta-IFN producers) 
in basal medium supplemented with a combination of the crude non-fractionated feed material 
and a specific fraction. PRI showed a similar growth enhancement effect for all fractions when 
compared to a culture supplemented with the crude non-fractionated. YE showed no growth 
enhancement for any of the fractions when compared to a culture supplemented with the crude 
non-fractionated YE. This observation need to be confirmed as a culture supplemented with the 
crude non-fractionated YE showed a very high growth stimulating effect which was much higher 
than PRI and YET at the same concentration. Finally, YET 3kDa retentate fraction displayed a 
50 % growth enhancement effect.  
In conclusion, the fractions obtained from the two non-animal protein hydrolysates considered in 
this study, YE and YET showed limited CHO cell growth enhancement effect when compared to 
the non-fractionated material. Only the YET 3kDa retentate fraction displayed a good CHO cell 
growth enhancement effect. YET 3kDa represent an attractive serum substitute for its use in 




enhancement effect for all fractions produced in this study. These results suggest that YET has 
high potential as a media additive for the development of serum-free media which can promote 
cell growth and, in the future this work can contribute in production of therapeutic proteins 
markets.    
 
Future work should consider growth experiments that include supplementation with only the  
individual fractions up to 0.05% in media in T25 flasks and analysis of the amino acids profiles 
to evaluate the amino acid consumption by the cells.  Also alternative methods for hydrolysate 
fractionation such as nanofiltration, which separates components according to size and charge, 
should be investigated. We can investigate other types of antioxidant capacity assays such as the 
ORAC assay which is based in hydrogen atom transfer (HAT) mechanism. This study did not 
find differences of hydrophobicity between the feed and the fractions through RP-HPLC of the 
untreated samples. Sample pre-treatment and different solvent and gradients should be 
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Appendix A    












1. Using Waterflux to find membrane resistance Rm 





















Rm (1/m)            
at 25 C 
Average 
Rm (1/m)                 
at 25 C 
10.00 6.89E+04 0.05 22.94 2.18E-06 7.59E-04 2.74E+00 2.79E+00 1.02E+14 1.00E+14 
10.00 6.89E+04 0.05 21.78 2.30E-06 8.00E-04 2.89E+00  9.65E+13 
  
10.00 6.89E+04 0.05 22.78 2.19E-06 7.65E-04 2.76E+00  1.01E+14 
  
10.00 6.89E+04 0.05 21.19 2.36E-06 8.22E-04 2.97E+00  9.39E+13 
  
10.00 6.89E+04 0.05 24.31 2.06E-06 7.17E-04 2.59E+00   1.08E+14   
15.00 1.03E+05 0.05 12.87 3.89E-06 1.35E-03 4.89E+00 5.01E+00 8.55E+13 8.35E+13 
15.00 1.03E+05 0.05 11.97 4.18E-06 1.46E-03 5.25E+00  7.95E+13 
  
15.00 1.03E+05 0.05 12.32 4.06E-06 1.41E-03 5.11E+00  8.18E+13 
  
15.00 1.03E+05 0.05 13.34 3.75E-06 1.31E-03 4.72E+00  8.86E+13 
  





Membrane area 0.00287 m
2
 
Water density 997.13 kg/m
3
 
Water viscosity 8.9E-04 Pa X second 
 
Example; use the first law of column data to find Rm 
 
Rm= (Pressure ⅩWater density)/(Permeate FluxⅩWater viscosity) 





2. Using feed solution to find Total resistance (the same method of Rm) 
Rt =(Pressure Ⅹ Feed solution density)/(Permeate Flux Ⅹ Feed solution viscosity) 


































Calculation of FCR assay 
 
 
The linear regression method, the absorbance of the solutions can be plotted from the standard 
solutions versus the antioxidant concentrations, and the standard curve best fitting the plotted 
points determined (Eq3.1). From the standard curve so obtained and the absorbance of the test 
solutions, the concentration of antioxidant in the test solution established.  
Calibration curve: y = ax + b 
*a-slop, b-intercept 
Concentration of Trolox mM : (Absorbance-intercept)/slop of calibration 








To calculate Phe-Gly concentration from calibration curve 
 
*Slop-0.0428, Intercept- 0.091 
 *Absorbance- 0.333  
 *Trolox MW- 250.29 g/mol 
Concentration of Trolox mM : (0.333-0.091)/0.0428= 5.65mM 
























Concentration of Trolox [mM]








Standard amino acid profile 



































Figure 8.2 Amino acid profiles with RP-HPLC C18 column and detection at 214nm (Glycine 
and Alanine was not detected)  
 






The growth curve of CHO cell in the serum-free basal medium supplemented with PRI and PRI 
fractions over 3 passages, mean (SE) of duplicate cultures at each of 3 culture passages (n=6), 
cell density (Ⅹ 104 cells/mL). 
     DAY 1 DAY 2 DAY 3 DAY 4      %growth 
ehancement  
50 kDa Re 14.67 44.00 109.33 177.67 38.9 
3 kDa Re 18.17 42.83 83.67 179.50 40.2 
1 kDa Re 13.00 42.67 103.00 171.67 34.5 
1 kDa Per 19.00 35.33 105.67 187.00 45.7 
Negative Control 16.00 35.67 90.00 124.67  
Positive Control 19.67 43.67 152.17 261.00  
 
 
The growth curve of CHO cell in the serum-free basal medium supplemented with YE and YE 
fractions over 3 passages,  mean (SE) of duplicate cultures at each of 3 culture passages (n=6), 
cell density (Ⅹ 104 cells/mL). 
 DAY 1 DAY 2 DAY 3 DAY 4 
%growth 
enhancement 
50 kDa re 15.33 56.33 96.50 217.00 - ve 
3 kDa re 17.33 51.33 101.00 185.00 -ve 
1 kDa re 21.00 52.00 95.50 216.33 -ve 
1 kDa per 14.00 53.67 90.50 199.67 -ve 
Negative Control 17.00 48.33 116.00 222.00  





The growth curve of CHO cell in the serum-free basal medium supplemented with YET and 
YET fractions over 3 passages, mean (SE) of duplicate cultures at each of 3 culture passages 
(n=6), cell density (Ⅹ 104 cells/mL). 
 DAY 1 DAY 2 DAY 3 DAY 4 
%growth 
enhancement 
50 kDa Re 17.00 58.00 103.67 125.00 3.1 
3 kDa Re 18.33 48.33 135.00 169.17 48.6 
1 kDa Re 17.17 49.50 106.67 144.00 22.7 
1 kDa Per 17.33 47.67 88.67 135.33 13.7 
Negative Control 19.00 48.67 77.33 122.00  
Positive Control 18.00 55.67 109.00 219.00 
 
Characterization of YET and its fractions followed by ultrafiltration  












1.01 0.15±0.02 0.22±0.04 0.24±0.01 0.28±0.01 
Phe-Gly 
[mmol] 












The growth curve of CHO cell in the serum-free basal medium supplemented with YE, YET and 
PRI 1 kDa retentate and permeate fractions over 3 passages,  mean (SE) of duplicate cultures at 
each of 3 culture passages (n=6), cell density (Ⅹ 104 cells/mL).  
A DAY 1 DAY 2 DAY 3 DAY 4 
PRI 1 kDa Re 13.00 42.67 103.00 171.67 
YE 1 kDa Re 21.00 52.00 95.50 216.33 
YET 1 kDa Re 17.17 49.50 106.67 144.00 
B DAY 1 DAY 2 DAY 3 DAY 4 
PRI 1 kDa Per 19.00 35.33 105.67 187.00 
YE1 kDa Per 14.00 53.67 90.50 199.67 
YET 1 kDa Per 17.33 47.67 88.67 135.33 
 
